NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/06/2026
Back to search
Official data from USPTO
QUANTON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
QUANTON
ST13
US500000079158317Class
5, 9, 42
Filing
79158317
Registration
4890835
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
05/07/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 42
Filing date
09/29/2014
Registration date
01/26/2016
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2026
Last transaction
05/07/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
Bensheim, DE
Examiner
CUCCIAS, MATTHEW JAMES
Current location
Historical data usage
Holders and representatives
Holders
Immundiagnostik AG
Immundiagnostik AG
Representatives
GABRIELLE S. ROTH SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic reagents for medical purposes; Diagnostic chemical reagents for medical purposes; Diagnostic chemical preparations for medical purposesfor diagnosing and monitoring gastroenterological diseasesinflammatory bowel syndromeinflammatory bowel diseasecolitis ulcerosaMorbus Crohn and for monitoring the effects of TNF-blocker on these conditions; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes ; diagnostic preparations for pharmaceutical purposes; reagents for in vitro laboratory tests for medical purposes; reagents for in vitro laboratory use for veterinary purposes
Class 9
Computer software for creating searchable databases containing information and data; computer software in the nature of a mobile application for use with immunochromatographic devices that test for a specific protein or antigen in a sample of body fluid or stoolfor which the software converts the analytical result to information that can be read by patients and physiciansusing mobile phones or smart phonesonce calibration data is downloaded from a global computer network; production lot encoded immunochromatographic devices that test for the presence of a specific protein or antigen in a sample of body fluid or stool which is converted to an analytical result that can be read by patients and physiciansusing mobile phones or smart phonesonce calibration data is downloaded from a global computer network; patient encoded immunochromatographic devices that determine the level of an antigen in a test samplethe results of which can be transmitted through use of a mobile app to a medical advisorphysician or doctor using a mobile phone or smart phone; machine readable immunochromatographic deviceshandheld immunochromatographic devices which produce test results that use a mobile app to scan and evaluate the results
Class 42
Biological researchclinical and medical research; design and programming of computer software in the medical field ; services of a chemical and biological laboratory; analysis of human sera for medical research; medical and pharmaceutical research services
Publications
History of USPTO decisions and trademark events.
56 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
05/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/04/2026
ES71
TEAS SECTION 71 RECEIVED
01/13/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
01/26/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/17/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
09/25/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/21/2023
INPC
INVALIDATION PROCESSED
08/21/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/25/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/25/2022
71AG
REGISTERED-SEC.71 ACCEPTED
11/25/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/22/2022
ES71
TEAS SECTION 71 RECEIVED
06/08/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/26/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/15/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/27/2016
FIMP
FINAL DISPOSITION PROCESSED
04/27/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/26/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/04/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2016
GPNX
NOTIFICATION PROCESSED BY IB
11/20/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2015
PUBO
PUBLISHED FOR OPPOSITION
11/10/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/04/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/04/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/02/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/23/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
09/14/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/14/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
09/14/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/14/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/09/2015
GNFR
FINAL REFUSAL E-MAILED
09/09/2015
CNFR
FINAL REFUSAL WRITTEN
09/09/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/17/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/17/2015
ALIE
ASSIGNED TO LIE
08/07/2015
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/31/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/27/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/09/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/09/2015
RFNP
REFUSAL PROCESSED BY IB
02/20/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/30/2015
RFRR
REFUSAL PROCESSED BY MPU
01/30/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/30/2015
CNRT
NON-FINAL ACTION WRITTEN
01/29/2015
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
01/23/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/23/2015
CNRT
NON-FINAL ACTION WRITTEN
01/22/2015
DOCK
ASSIGNED TO EXAMINER
01/19/2015
MAFR
APPLICATION FILING RECEIPT MAILED
01/13/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/02/2015
Continuous trademark protection
Get notified about every new filing that threatens QUANTON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.